|Education||Christ's College, Cambridge|
|Net worth||US$1.59 billion (February 2018)|
|Successor||M. K. Hamied|
|Parent(s)||Khwaja Abdul Hamied|
Yusuf Khwaja Hamied (born 25 July 1936) is a Polish-born-Indian scientist, billionaire businessman, the chairman of Cipla, a generic pharmaceuticals company founded by his father Khwaja Abdul Hamied in 1935. He is also an elected fellow of the Indian National Science Academy.
Hamied was born in Vilnius, Lithuania, and raised in Bombay (now Mumbai). His north Indian Muslim father and Russophone Lithuanian Jewish mother met in pre-war Berlin, where they were university students. Hamied was educated at the Cathedral and John Connon School and St. Xavier's College, Mumbai. He later went to England and earned a PhD in chemistry from Christ's College, Cambridge. He uses his chemistry notebooks from Cambridge when he develops new syntheses of drugs.
Hamied is best known outside India for defying large Western pharmaceutical companies in order to provide generic AIDS drugs and treatments for other ailments primarily affecting people in poor countries. Hamied has led efforts to eradicate AIDS in the developing world and to give patients life-saving medicines regardless of their ability to pay, and has been characterized as a modern-day Robin Hood figure as a result.
Hamied stated, "I don't want to make money off these diseases which cause the whole fabric of society to crumble".
Dr. Yusuf K. Hamied, chairman of the Indian drug giant Cipla Ltd., electrified the global health community a decade ago when he said he could produce cocktails of AIDS medicines for $1 per day — a fraction of the price charged by branded pharmaceutical companies. That price has since fallen to 20 cents per day, and more than six million people in the developing world now receive treatment, up from little more than 2,000 in 2001.
Hamied has also been influential in pioneering development of multi-drug combination pills (also known as fixed-dose combinations, or FDCs), notably for HIV/AIDS, tuberculosis (TB), asthma and other ailments chiefly affecting developing countries, as well as development of pediatric formulations of drugs, especially those benefiting children in poor settings. These innovations have greatly expanded access to medicine and increased drug safety by ensuring proper dosages are taken. He is also highly regarded for his role in expanding the production of bulk drugs and "active pharmaceutical ingredients" (APIs, the active chemical components in medicines) in India.
Hamied has been the subject of in-depth profiles in The New York Times, Time magazine, The Guardian, Le Monde, The Economist, the Financial Times, The Times (London), Corriere della Sera, Der Spiegel, Wired and numerous other leading publications, as well as on television outlets such as ABC News, the BBC, CNN and CBS' 60 Minutes.
In February 2013, Hamied announced his retirement plans from Cipla after remaining managing director of the company for 52 years. That year, Forbes magazine included him in its list of richest Indians.
Awards and recognition
Hamied was awarded the 'CNN-IBN Indian of the Year' in the category of business by CNN-IBN in 2012 "for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries." In late 2013, he was also named one of the India's "25 Greatest Global Living Legends" by news broadcaster NDTV. He was also recently interviewed for the Creating Emerging Markets project at the Harvard Business School, discussing at length his strategies to provide AIDS treatments and other drugs to help treat poor people in the developing world.
Hamied's role in the battle for mass antiretroviral treatment in Africa is portrayed in the documentary Fire in the Blood (2013 film). In its review of the film, India Today noted that "the story of Yusuf Hamied will make every Indian proud as he was the only man who decided to walk against the tide and sell drugs to save lives without focusing on profits."
His younger brother, M. K. Hamied, is Cipla's non-executive vice-chairman. The latter has three children, including Samina Vaziralli, who is expected to take over leadership of Cipla in the future.
- "Yusuf Hamied". Forbes. Retrieved 25 February 2018.
- Sarah Boseley (18 February 2003). "Yusuf Hamied, generic drugs boss | World news". The Guardian. London. Retrieved 1 September 2010.
- "Fellows Elected 2019" (PDF). Indian National Science Academy. Archived from the original (PDF) on 2 August 2019. Retrieved 2 August 2019.
- Donald G. McNeil Jr (1 December 2000). "Selling Cheap 'Generic' Drugs, India's Copycats Irk Industry". The New York Times. Retrieved 26 January 2016.
- "Indian drugs boss hails Aids deal". 29 October 2003. Retrieved 7 September 2016.
- "Interview of the week: Yusuf Hamied. - United Press International | HighBeam Research - FREE trial". Highbeam.com. 22 February 2001. Retrieved 1 September 2010.[dead link]
- "Yusuf Hamied, un Robin Hood contro l' Aids "Così sconfiggerò l' Aids senza le multinazionali"". Archiviostorico.corriere.it. Retrieved 26 January 2016.
- Bobin, Frédéric (6 July 2010). "India fears generic drugs for poor are endangered by proposed EU trade deal". The Guardian. London.
- "TransIP - Reserved domain". Legacy.laika.nl. Retrieved 26 January 2016.
- "English Summaries - SPIEGEL ONLINE". Spiegel.de. 2 April 2001. Retrieved 26 January 2016.
- Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012.
- Harris, Gardiner (18 September 2011). "China and India Making Inroads in Biotech Drugs". The New York Times.
- Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 58-59
- Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 63
- "Christ's officially opens Yusuf Hamied Centre". University of Cambridge News. 20 April 2009. Retrieved 20 April 2009.
- "The Hindu News Update Service". Chennai, India: Hindu.com. 22 April 2009. Retrieved 1 September 2010.
- "Cambridge salutes Mumbai boy". Mid Day. Retrieved 30 October 2016.
- "Yusuf Hamied, generic drugs boss". 18 February 2003. Retrieved 7 September 2016.
- "Grand old man of Cipla Yusuf K Hamied hangs his boots". Economic Times. 7 February 2013. Retrieved 8 November 2013.
- "Padma Awards Directory (1954–2009)" (PDF). Ministry of Home Affairs. Archived from the original (PDF) on 10 May 2013.
- "Dr. Yusuf Hamied message on being CNN-IBN's Indian of The Year 2012 in the business category". CNN-IBN. 17 December 2012. Retrieved 8 November 2013.
-  Archived January 9, 2014, at the Wayback Machine
- "Interview with Yusuf Hamied". Creating Emerging Markets. Harvard Business School.
- on YouTube
- "The Contributors". Fire in the Blood. 20 January 2013. Retrieved 26 January 2016.
- "Movie Review: Fire in the Blood". 10 October 2013. Retrieved 7 September 2016.
- "Undiplomatic departure from London". Telegraphindia.com. Retrieved 26 January 2016.
- "Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leaders". Articles.economictimes.indiatimes.com. Retrieved 26 January 2016.